FineMark National Bank & Trust’s Cantel Medical Corporation CMD Stock Holding History

FineMark National Bank & Trust’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,825	Closed	-$226K	–	457
2021 Q1	$226K	Hold	2,825	–	–	0.01%	406
2020 Q4	$223K	Buy	+2,825	New	+$166K	0.01%	383
2017 Q1	–	Sell	-34	Closed	-$3K	–	1102
2016 Q4	$3K	Sell	34 -9	-21%	-$699	﹤0.01%	1138
2016 Q3	$3K	Hold	43	–	–	﹤0.01%	1144
2016 Q2	$3K	Sell	43 -7	-14%	-$483	﹤0.01%	1169
2016 Q1	$4K	Hold	50	–	–	﹤0.01%	1076
2015 Q4	$3K	Hold	50	–	–	﹤0.01%	1127
2015 Q3	$3K	Hold	50	–	–	﹤0.01%	1202
2015 Q2	$3K	Buy	+50	New	+$2.43K	﹤0.01%	1213

FineMark National Bank & Trust's CMD Position: Q2 2021 in Review

FineMark National Bank & Trust sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 2,825 shares — an estimated $226K sold.

FineMark National Bank & Trust first reported a position in CMD in Q2 2015 and held it in 9 quarters. The position peaked at $226K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

FineMark National Bank & Trust reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
FineMark National Bank & Trust sold 2,825 Cantel Medical Corporation shares in Q2 2021, an estimated $226K.
FineMark National Bank & Trust first reported a position in Cantel Medical Corporation in Q2 2015 and held it in 9 quarters.
FineMark National Bank & Trust's Cantel Medical Corporation position peaked at $226K in Q1 2021.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on FineMark National Bank & Trust's 13F filing for Q2 2021, filed 13 Aug 2021.